Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis [Phase 3]

View source ↗

Summary

Phase 3 trial of Brensocatib in Non-Cystic Fibrosis Bronchiectasis completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• Brensocatib (brensocatib)

Snippet

Sponsor: Insmed Incorporated | Conditions: Non-Cystic Fibrosis Bronchiectasis | Phase 3 | Status: COMPLETED | Results posted: 2025-12-16